- Home
- Publications
- Publication Search
- Publication Details
Title
Options for treating different soft tissue sarcoma subtypes
Authors
Keywords
-
Journal
Future Oncology
Volume 14, Issue 10s, Pages 25-49
Publisher
Future Medicine Ltd
Online
2018-05-17
DOI
10.2217/fon-2018-0076
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour
- (2017) S. Stacchiotti et al. EUROPEAN JOURNAL OF CANCER
- The importance of treating by histological subtype in advanced soft tissue sarcoma
- (2017) Javier Martín Broto et al. Future Oncology
- Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: A retrospective MITO group study
- (2017) Francesco Raspagliesi et al. GYNECOLOGIC ONCOLOGY
- Uterine leiomyosarcoma: Epidemiology, contemporary treatment strategies and the impact of uterine morcellation
- (2017) Stephanie Ricci et al. GYNECOLOGIC ONCOLOGY
- Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
- (2017) Alessandro Gronchi et al. LANCET ONCOLOGY
- Long-term Results of Therapy with Sunitinib in Metastatic Alveolar Soft Part Sarcoma
- (2017) Paulina Jagodzińska-Mucha et al. TUMORI
- Pharmacological therapies for Liposarcoma
- (2017) Maristella Saponara et al. Expert Review of Clinical Pharmacology
- Long-term Results of Therapy with Sunitinib in Metastatic Alveolar Soft Part Sarcoma
- (2017) Paulina Jagodzińska-Mucha et al. TUMORI JOURNAL
- Dedifferentiated Liposarcoma
- (2016) Khin Thway et al. ADVANCES IN ANATOMIC PATHOLOGY
- Impact of chemotherapy in uterine sarcoma (UtS): review of 13 clinical trials from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) involving advanced/metastatic UtS compared to other soft tissue sarcoma (STS) patients treated with first line chemotherapy
- (2016) I. Ray-Coquard et al. GYNECOLOGIC ONCOLOGY
- Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial
- (2016) George D. Demetri et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma Group
- (2015) J. Khalifa et al. BMC CANCER
- Trabectedin in patients with advanced soft tissue sarcoma: A retrospective national analysis of the French Sarcoma Group
- (2015) Axel Le Cesne et al. EUROPEAN JOURNAL OF CANCER
- Trabectedin clinical cases: use according to indication in diverse clinical scenarios
- (2015) Giovanni Grignani et al. Future Oncology
- Complete response of a recurrent-metastatic liposarcoma with dedifferentiated histological features following the administration of trabectedin and review of literature
- (2015) Tulay Kus et al. Journal of Cancer Research and Therapeutics
- Patterns of Chemotherapy Administration in High-Risk Soft Tissue Sarcoma and Impact on Overall Survival
- (2015) Sujana Movva et al. Journal of the National Comprehensive Cancer Network
- Assessing the Multimodal Management of Advanced Solitary Fibrous Tumors of the Pleura in a Routine Practice Setting
- (2015) Olivier Bylicki et al. Journal of Thoracic Oncology
- Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study
- (2015) Akira Kawai et al. LANCET ONCOLOGY
- Solitary fibrous tumors: loss of chimeric protein expression and genomic instability mark dedifferentiation
- (2015) Gian P Dagrada et al. MODERN PATHOLOGY
- Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations
- (2015) David M. Hyman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Synovial Sarcoma: Recent Discoveries as a Roadmap to New Avenues for Therapy
- (2015) Torsten O. Nielsen et al. Cancer Discovery
- Prognostic value of SS18–SSX fusion type in synovial sarcoma; systematic review and meta-analysis
- (2015) Tadahiko Kubo et al. SpringerPlus
- Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2014) ANNALS OF ONCOLOGY
- Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma
- (2014) Suzanne George et al. CANCER
- Trabectedin for advanced soft tissue sarcomas: a single institution experience
- (2014) Ioannis Gounaris et al. Future Oncology
- Soft tissue sarcomas, a look into the future: different treatments for different subtypes
- (2014) Peter Reichardt Future Oncology
- Gynecologic Cancer InterGroup (GCIG) Consensus Review
- (2014) Martee L. Hensley et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Clinical outcomes and safety with trabectedin therapy in patients with advanced soft tissue sarcomas following failure of prior chemotherapy: results of a worldwide expanded access program study
- (2013) B. L. Samuels et al. ANNALS OF ONCOLOGY
- Long-term outcome and effect of maintenance therapy in patients with advanced sarcoma treated with trabectedin: an analysis of 181 patients of the French ATU compassionate use program
- (2013) Jean-Yves Blay et al. BMC CANCER
- Phase 2 trial of aromatase inhibition with letrozole in patients with uterine leiomyosarcomas expressing estrogen and/or progesterone receptors
- (2013) Suzanne George et al. CANCER
- Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma
- (2013) Martee L. Hensley et al. CANCER
- Response to chemotherapy of solitary fibrous tumour: A retrospective study
- (2013) S. Stacchiotti et al. EUROPEAN JOURNAL OF CANCER
- Liposarcomas: diagnostic pitfalls and new insights
- (2013) Angelo P Dei Tos HISTOPATHOLOGY
- Sorafenib in patients with progressive malignant solitary fibrous tumors: a subgroup analysis from a phase II study of the French Sarcoma Group (GSF/GETO)
- (2013) T. Valentin et al. INVESTIGATIONAL NEW DRUGS
- Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors
- (2013) Juliann Chmielecki et al. NATURE GENETICS
- Novel Systemic Therapies in Advanced Liposarcoma: A Review of Recent Clinical Trial Results
- (2013) William Tseng et al. Cancers
- Sunitinib malate in solitary fibrous tumor (SFT)
- (2012) S. Stacchiotti et al. ANNALS OF ONCOLOGY
- A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group
- (2012) P. Pautier et al. ANNALS OF ONCOLOGY
- Incidence of soft tissue sarcoma and beyond
- (2012) Giuseppe Mastrangelo et al. CANCER
- Efficacy of Trabectedin in Patients with Advanced or Metastatic Alveolar Soft-Part Sarcoma
- (2012) Daniel Pink et al. ONKOLOGIE
- Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor
- (2011) Min S. Park et al. CANCER
- Pleomorphic liposarcoma
- (2011) Markus P. Ghadimi et al. CANCER
- Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma
- (2011) Aimee M Crago et al. CURRENT OPINION IN ONCOLOGY
- Trabectedin in advanced uterine leiomyosarcomas: A retrospective case series analysis from two reference centers
- (2011) Roberta Sanfilippo et al. GYNECOLOGIC ONCOLOGY
- Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing
- (2011) Françoise Ducimetière et al. PLoS One
- Optimal management of uterine leiomyosarcoma
- (2010) Roisin O’Cearbhaill et al. Expert Review of Anticancer Therapy
- Angiosarcoma
- (2010) Robin J Young et al. LANCET ONCOLOGY
- Response to Sunitinib Malate in Advanced Alveolar Soft Part Sarcoma
- (2009) S. Stacchiotti et al. CLINICAL CANCER RESEARCH
- Predictive value of FIGO and AJCC staging systems in patients with uterine leiomyosarcoma
- (2009) Chandrajit P. Raut et al. EUROPEAN JOURNAL OF CANCER
- Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas
- (2009) Stefan Sleijfer et al. EUROPEAN JOURNAL OF CANCER
- Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)
- (2009) Stefan Sleijfer et al. JOURNAL OF CLINICAL ONCOLOGY
- Translocation-Related Sarcomas
- (2009) Fredrik Mertens et al. SEMINARS IN ONCOLOGY
- A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma
- (2008) Nabeel Pervaiz et al. CANCER
- Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)
- (2008) N.S. Reed et al. EUROPEAN JOURNAL OF CANCER
- Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II study
- (2008) Martee L. Hensley et al. GYNECOLOGIC ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started